Devices marketed as “electronic cigarettes” are in reality crude drug delivery systems for refined nicotine, posing unknown risks with little new benefits to smokers, according to tobacco control experts. In a new article, researchers explore the current regulatory climate around “e-cigarettes” and their safety. They also question future implications for physicians, policy makers and e-cigarette users.